The Medicines Company (MDCO) PT Raised to $55 at Citi After PH3 Inclisiran Data Presentation
Tweet Send to a Friend
Citi analyst Joel Beatty raised the price target on The Medicines Company (NASDAQ: MDCO) to $55.00 (from $48.00) after after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
